糖尿病大鼠肝细胞膜胰岛素受体的变化及机制探讨

本文采用受体的放射配体分析法,观察链佐霉素（ＳＴＺ）糖尿病大鼠肝细胞膜胰岛素受体的变化,并用核酸杂交方法对ＳＴＺ大鼠肝组织胰岛素受体变化的机制进行探讨。主要结果如下,Ｗｉｓｔａｒ大鼠在腹腔注射ＳＴＺ后２周,血糖升高,血清胰岛素水平降低,肝细胞膜胰岛素受体数目增加,与正常对照组相比增加了１５５．６％,而受体结合的亲和力下降。用斑点杂交方法观察到,ＳＴＺ注射２周后,大鼠肝组织胰岛素受体ｍＲＮＡ含量明显增加,而补充胰岛素后,受体ｍＲＮＡ含量基本恢复正常。提示ＳＴＺ大鼠肝细胞膜胰岛素受体数目增加的原因,可能主要是低胰岛素血症引起肝组织胰岛素受体ｍＲＮＡ表达水平增加,而补充胰岛素可使其恢复正常。从而进一步证明,血清胰岛素水平在ＳＴＺ糖尿病大鼠肝细胞膜胰岛素受体的变化中具有重要作用。     

Cyclic AMP induces rapid increases in gap junction permeability and changes in the cellular distribution of connexin43

The rapid effects of cAMP on gap junction-mediated intercellular communication were examined in several cell types which express different levels of the gap junction protein, connexin43 (Cx43), including immortalized rat hepatocyte and granulosa cells, bovine coronary venular endothelial cells, primary rat myometrial and equine uterine epithelial cells. Functional analysis of changes in junctional communication induced by 8-bromo-cAMP was monitored by a fluorescence recovery after photobleaching assay in subconfluent cultures in the presence or absence of 1.0 mm 1-octanol (an agent which uncouples cells by closing gap junction channels). Communicating cells treated with 1.0 mm 8-bromo-cAMP alone exhibited significant increases in the percent of fluorescence recovery which were detected within 1–3 min depending on cell type, and junctional communication remained significantly elevated for up to 24 hr. Addition of 1.0 mm 8-bromo-cAMP to cultured cells, which were uncoupled with 1.0 mm octanol for 1 min, exhibited partial restoration of gap junctional permeability beginning within 3–5 min. Identical treatments were performed on cultures that were subsequently processed for indirect immunofluorescence to monitor Cx43 distribution. The changes in junctional permeability of cells correlated with changes in the distribution of immunoreactive Cx43. Cells treated for 2 hr with 10 m monensin exhibited a reduced communication rate which was accompanied by increased vesicular cytoplasmic Cx43 staining and reduced punctate surface staining of junctional plaques. Addition of 1.0 mm 8-bromo-cAMP to these cultures had no effect on the rate of communication or the distribution of Cx43 compared to cultures treated with monensin alone. These data suggest that an effect of cyclic AMP on Cx43 gap junctions is to promote increases in gap junctional permeability by increasing trafficking and/or assembly of Cx43 to plasma membrane gap junctional plaques.We acknowledge the technical assistance of Richard Lewis and Meghan Abella. We thank Dr. Hugh Dookwah for contributions to the myometrial cell isolation protocol and Drs. Stephen H. Safe, Timothy D. Phillips, and Evelyn Tiffany-Castiglioni for helpful discussions. This work was funded by NIH (HD-26182, P42-ES04917, ES05871-01A1), the March of Dimes Birth Defects Foundation Basic Research grant #1-0796, and USDA 92-37203-7952.     

Insulin receptor binding from mid-term and full-term placentas of patients with gestational diabetes mellitus and normal pregnant women

Insulin receptor binding was examined in the microvillous membranes of mid-term (20–22 weeks of gestation, MT) and full-term (FT) placentas from patients with gestational diabetes mellitus (GDM) and in normal pregnant control (N). Mid-term placentas were obtained from patients who have had spontaneous abortion. The maximum per cent specific binding (%SB) in MT placenta for GDM was significantly lower (4.8%) compared with the FT placenta (22%, p<0.001), while in the N group the maximum per cent specific binding for MT placenta was 14.1% compared with 26% for the FT placneta (p<0.001). Binding data from FT placenta of well-controlled GDM patients were similar with the FT placenta from N group (22%SB for GDM VS 26% SB for N). Even as there were similarities in the binding characteristics of FT placentas from both groups the placental membrane protein content in the GDM group was lower by 50% compared with the N control (2.5±0.11 VS 4.8±0.15 mg protein/g placenta respectively, p<0.001) suggesting that in the GDM group achieving a tight glycemic control could improve receptor affinities. Data from the competitive binding assay of GDM patients showed that the insulin necessary to achieve 50% inhibition (ID₅₀) was significantly lower in MT compared with the FT placenta (0.9×10^–9 M VS 3.8×10^–9 M, p<0.001) but in the N placenta there was no alteration in the ID₅₀ of MT and FT placentas (3.1×10^–9 M VS 4×10^–9 M, p<0.01, respectively). The present study demonstrated that in GDM the placental insulin receptor binding was significantly lower in spontaneously aborted placenta compared with placentas collected at full-term. Furthermore, these data suggest that the objective to achieve a tight glycemic control in GDM patients could optimize insulin receptor function similar to that of a normal pregnancy. Thus a full term placenta from GDM patients under a well managed glycemic control throughout the entire duration of pregnancy would result in an optimum insulin receptor function.     

Increased potency of vanadium using organic ligands

Thein vivo glucose lowering effect of orally administered inorganic vanadium compounds in diabetes was first reported in our laboratory in 1985. While both vanadate and vanadyl forms of vanadium are orally active, they are still not well absorbed. We have synthesized several organic vanadium compounds and one compound, bis(maltolato)oxovanadium(IV) or BMOV, has been extensively investigated. BMOV proved effective in lowering plasma glucose and lipids in STZ-diabetic rats when administered in drinking water over a 25 week period. The maintenance dose (0.18 mmol/kg/day) was approximately 50% of that required for vanadyl sulfate (VS). Secondary complications of diabetes were prevented by BMOV and no marked toxicity was noted. Oral gavage of STZ-diabetic rats with BMOV also reduced blood glucose levels. The ED₅₀ for BMOV was 0.5 mmol/kg, while for VS the estimated ED₅₀ was 0.9 mmol/kg. BMOV was also effective by the intraperitoneal route in STZ-diabetic rats. The ED₅₀ was 0.08 mmol/kg compared to 0.22 mmol/kg for VS. Some animals treated p.o. or i.p. remained euglycemic for up to 14 weeks. An i.v. infusion of BMOV of 0.05 mmol/kg over a 30 min period reduced plasma glucose levels by 50% while VS was not effective.     

Toxicology of vanadium compounds in diabetic rats: The action of chelating agents on vanadium accumulation

The possible use of vanadium compounds in the treatment of diabetic patients is now being evaluated. However, previously to establish the optimal maximum dose for diabetes therapy, it should be taken into account that vanadium is a highly toxic element to man and animals. The toxic effects of vanadium are here reviewed. The tissue vanadium accumulation, which would mean an additional risk of toxicity following prolonged vanadium administration is also discussed. Recently, it has been shown that coadministration of vanadate and TIRON, an effective chelator in the treatment of vanadium intoxication, reduced the tissue accumulation of this element, decreasing the possibility of toxic side effects derived from chronic vanadium administration without diminishing the hypoglycemic effect of vanadium. However, previously to assess the effectiveness of this treatment in diabetic patients, a critical reevaluation of the antidiabetic action of vanadium and its potential toxicity is clearly needed.     

In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals

The insulin-mimetic action of vanadate is well established but the exact mechanism by which it exerts this effect is still not clearly understood. The role of insulin in the regulation of hepatic glycogen metabolizing and lipogenic enzymes is well known. In our study, we have, therefore, examined the effects of vanadate on these hepatic enzymes using four different models of diabetic and insulin-resistant animals. Vanadate normalized the blood glucose levels in all animal models. In streptozotocin-induced diabetic rats, the amount of liver glycogen and the activities of the active-form of glycogen synthase, both active and inactive-forms of phosphorylase, and lipogenic enzymes like glucose 6-phosphate dehydrogenase and malic enzyme were decreased and vanadate treatment normalized all of these to near normal levels. The other three animal models (db/db mouse, sucrose-fed rats and fa/fa obese Zucker rats) were characterized by hyperinsulinemia, hypertriglyceridemia, increases in activities of lipogenic enzymes, and marginal changes in glycogen metabolizing enzymes. Vanadate treatment brought all of these values towards normal levels. It should be noted that vanadate shows differential effects in the modulation of lipogenic enzymes activities in type I and type II diabetic animals. It increases the activities of lipogenic enzymes in streptozotocin-induced diabetic animals and prevents the elevation of activities of these enzymes in hyperinsulinemic animals. The insulin-stimulated phosphorylation of insulin receptor subunit and its tyrosine kinase activity was increased in streptozotocin-induced diabetic rats after treatment with vanadate. Our results support the view that insulin receptor is one of the sites involved in the insulin-mimetic actions of vanadate.     

A special moult after the release of the embryo from the brood pouch of Anomopoda (Branchiopoda,Crustacea): a return to an old question

In the past there were doubts about the existence of a especialmoult after the release of an anomopod embryo from the maternalbrood pouch. This moult occurs in all studied anomopods and marksthe beginning of the first juvenile instar. The term neonata (orneanate) must be applied to the unexpanded animal (the terminalphase of embryogenesis) before this moult, and not to the earlyphase of the first postembryonic instar. The latter is the nextstage of development. Using knowledge of the presence of thismoult, it is possible to understand and explain the contradictionsin the periodization of postembryonic development as described bydifferent authors. Under normal conditions males of bosminids andevolutionarily advanced chydorids have only two juvenile instars(with specific morphology) in the course of development. This is anadditional argument to support the idea of close relationship ofthe families Chydoridae and Bosminidae.     

人胚DA能神经元移植于帕金森氏病猴模型的TH免疫细胞化学的研究

为了对人胚黑质ＤＡ神经元移植治疗ＰＤ人的临床应用作出客观评估,将８－１２周人胚黑质细胞移植到用ＭＰＴＰ诱发的偏侧ＰＤ猴新纹状体内。实验动物分别存活２个月、５个月和１年后,用ＴＨ免疫细胞化学方法对被移植的人胚ＤＡ细胞的存活和与宿主间的突触联系进行检查。在光镜下可见被移植侧的新纹状体内有ＴＨ阳性细胞,它们成小群散在分布,每小群有３－１０个细胞。ＴＨ阳性细胞的轴突延伸到整个新纹状体,树突呈现出正常发育过     

Nutrients in the shadow-nutrients of substance

While the dietary importance of proteins, essential fatty acids, vitamins and trace elements has been well recognised, the role of shadow nutrients, a class of metabolites, which are biosynthesized in the body and serve vital functions, such as lipoic acid, choline, inositol, taurine and carnitine, has not been adequately appreciated. There are reasons to believe that during infancy and in ageing, biosynthesis of these metabolites may be limited. The objective of this review is to highlight the essentiality of these nutrients and the need for their supplementation in the diets of infants and in elderly people. Provision of shadow nutrients where the necessary biosynthetic machinery might not have developed to full stature or might have slowed down, is a new concept in nutrition which needs attention.